SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

                                   (Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

                 For the quarterly period ended August 31, 2004

                                       OR

[ ] TRANSITION REPORT UNDER SECTION 13 OF 15(D) OF THE EXCHANGE ACT OF 1934

          From the transition period from              to             .
                                          -------------  ------------

                         Commission File Number 0-29439
                                                -------


                            TWISTEE TREAT CORPORATION
                            -------------------------
        (Exact name of small business issuer as specified in its charter)


                               Delaware 43-1796315
                               -------------------
    (State or other jurisdiction of incorporation or organization)(IRS Employer
                               Identification No.)


                 2983 Ravenswood Rd., Fort Lauderdale, FL 33312
                 ----------------------------------------------
                    (Address of principal executive offices)


                                  (877) 667-9377
                                  --------------
                           (Issuer's telephone number)


                                      N/A
                                      ---
   (Former name, former address and former fiscal year, if changed since last
                                    report)

     Indicate by check mark whether the registrant (1) filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days:

                                   Yes: X    No:
                                       --

As of August 31, 2004 7,577,795 shares of Common Stock of the issuer were
outstanding.

<PAGE>

                            TWISTEE TREAT CORPORATION
                                   FORM 10-QSB

                                      INDEX


                                     PART I

Item 1.     Financial Statements                                               3

Item 2.     Management's Discussion and Analysis of Financial Condition
            and Results of Operations                                          6

                                    PART II

Item 1.     Legal Proceedings                                                  9

Item 6.     Exhibits and Reports on Form 8-K                                   9

            Signatures                                                        10


<PAGE>


<TABLE>
<CAPTION>

                            TWISTEE TREAT CORPORATION
                                  BALANCE SHEET
                                 August 31, 2004

                                                                AS AT
                                                              AUGUST 31
                                                                 2004
<S>                                                          <C>
ASSETS

Current assets
   Cash                                                      $         -
   Accounts receivable                                                 -
                                                             ------------
Total current assets                                                   -
                                                             ------------
Fixed Assets
   Property and equipment, net                                         -
                                                             ------------
Total fixed assets                                                     -
                                                             ------------
Total assets                                                 $         -
                                                             ============

LIABILITIES AND STOCKHOLDER'S DEFICIT

Current liabilities
   Accounts payable and accrued expenses                     $   196,033
   Advances - shareholders                                        37,000
   Note payable - shareholders                                    20,000
                                                             ------------
Total current liabilities                                        253,033
                                                             ------------

STOCKHOLDER'S DEFICIT
   Preferred stock, $.0001 par value, 10,000,000 authorized
     no shares issued and outstanding                                  -
   Common stock, $.0001 par value, 50,000,000 authorized
     7,577,795 shares issued and outstanding                         758
Additional paid in capital                                     3,900,274
Accumulated deficit                                           (4,054,065)
                                                                (104,660)
Less: subscriptions receivable                                  (100,000)
                                                             ------------
Total stockholder's Deficit                                     (253,033)

TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT                  $         -
                                                             ============
</TABLE>

                                      -3-
<PAGE>

<TABLE>
<CAPTION>

                                    TWISTEE TREAT CORPORATION
                                      STATEMENTS OF EXPENSES


                                                   THREE MONTHS ENDED         NINE MONTHS ENDED
                                                        AUGUST 31                 AUGUST 31
                                                   2004         2003         2004         2003
<S>                                             <C>          <C>          <C>          <C>
Sales                                                    -            -            -            -
   Cost of sales                                         -            -            -            -
Gross profit                                             -            -            -            -

Payroll and contractual expenses                         -       15,000            -       59,855
General administrative and operating expenses          282        5,479       31,558       11,065
Consulting expense                                       -            -       30,000       43,800
Legal and accounting fees                                -          800            -        2,800
Depreciation and impairment expense                 53,748        6,948       64,498       20,844
                                                -------------------------------------------------
                                                    54,030       28,227      126,056      138,364
                                                -------------------------------------------------

Income (loss) from operations                      (54,030)     (28,227)    (126,056)    (138,364)

Interest expense                                     1,340            -        4,020            -
                                                -------------------------------------------------
Net income (loss)                               $  (55,370)  $  (28,227)  $ (130,076)  $ (138,364)
                                                =================================================
Basic and diluted income (loss)                 $    (0.01)  $    (0.01)  $    (0.02)  $    (0.03)
per common share

Weighted average shares outstanding              7,577,795    5,607,795    7,003,250    4,992,102
</TABLE>

                                      -4-
<PAGE>

<TABLE>
<CAPTION>

                            TWISTEE TREAT CORPORATION
                            STATEMENTS OF CASH FLOWS


                                                        NINE MONTHS ENDED
                                                            AUGUST 31
                                                         2004       2003
<S>                                                    <C>        <C>
Cash flows from operating activities
  Net income (loss)                                    (130,076)  (138,364)
    Adjustments to reconcile net income to net cash
      used in operating activities:
    Depreciation                                         16,125     20,844
    Impairment                                           48,373          -
  Changes in assets and liabilities
    Accounts payable and accrued expenses                63,624      3,552
                                                       --------------------
Net cash provided (used) in operating activities         (1,954)  (113,968)
                                                       --------------------

Cash flows from financing activities
  Proceeds from shareholder advances                          -      7,000
  Proceeds from sale of common stock                          -     92,960
                                                       --------------------
Net cash provided (used) by financing activities              -     99,960
                                                       --------------------

Net increase (decrease) in cash and cash equivalents     (1,954)   (14,008)
                                                       --------------------
Cash and cash equivalents at beginning of period          1,954     15,962
                                                       --------------------
Cash and cash equivalents at end of period                    -      1,954
                                                       --------------------
</TABLE>

                                      -5-
<PAGE>

                            TWISTEE TREAT CORPORATION
                          NOTES TO FINANCIAL STATEMENTS

NOTE 1 - PRESENTATION

The balance sheet of the Company as of August 31, 2004, the related statements
of operations for the three months and nine months ended August 31, 2004 and
2003 and the statements of cash flows for the nine months ended August 31, 2004
and 2003 included in the financial statements have been prepared by the Company
without audit.  In the opinion of management, the accompanying financial
statements include all adjustments (consisting of normal, recurring adjustments)
necessary to summarize fairly the Company's financial position and results of
operations.  The results of operations for the nine months ended August 31, 2004
are not necessarily indicative of the results of operations for the full year or
any other interim period.  The information included in this Form 10-QSB should
be read in conjunction with Management's Discussion and Analysis and Financial
Statements and notes thereto included in the Twistee Treat Corporation's
November 30, 2003 Form 10-KSB.


NOTE 2 - OPTIONS

In November 2004, the board of directors extended the terms of the options to
two officers from November 11, 2004 through November 11, 2005.  The options are
exercisable at $0.03.


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS

This report contains forward looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended. The Company's actual results could differ
materially from those set forth on the forward looking statements as a result of
the risks set forth in the Company's filings with the Securities and Exchange
Commission, general economic conditions, and changes in the assumptions used in
making such forward looking statements.

GENERAL OVERVIEW

Overview.

Twistee Treat operated and franchised soft-serve ice cream desserts and an
assortment of other foods and beverages in its proprietary, cone-shaped
buildings and kiosks.  Incorporated in Missouri in 1997, the Company
re-domiciled by merger into a Delaware corporation in June of 1999 with the name
Twistee Treat Corporation.  On April 6, 2000, the Company purchased a
publicly-reporting Nevada corporation, Perfection Plus, Inc., as described more
fully in our Form 8-K filed with the Securities and Exchange Commission on April
8, 2000, and as subsequently amended.  During the nine months ended August 31,
2004, the Company did not have any operations and had three inactive franchises.

                                      -6-
<PAGE>

RESULTS OF OPERATIONS

THREE MONTHS ENDED AUGUST 31, 2004 COMPARED TO THREE MONTHS ENDED AUGUST 31,
2003

There were no net sales for the three and nine months ended August 31, 2004 and
2003, respectively.  The Company is pursuing strategic partners or merger
candidates.

Operating expenses for the three months ended August 31, 2004 increased by
$25,803 or 92% to $54,030 from $28,227 for the corresponding period of the prior
year.  The increase is attributable to the Company writing off the remaining
fixed assets which was offset by a reduction in administrative and operating
expenses.

For the nine month period ending August 31, 2004 operating expenses decreased
$12,308 or 9% to $126,056 from $138,364 for the corresponding period of the
prior year. The decrease is attributable to a decrease in consulting,
professional fees and salaries offset by an increase in depreciation expense due
to the impairment of the molds.

Net loss for the three months ended August 31, 2004 increased by $27,143 to a
loss of $55,370 from a loss of $28,227 for the corresponding period of the prior
year.  For the three months ended August 31, 2004 and 2003 the Company did not
record a tax benefit.

For the nine months ended August 31, 2004, the net loss decreased $8,288 to a
loss of $130,076 from a net loss of $138,364 for the corresponding period of the
previous year.  The Company did not record a tax benefit for the six months
ended August 31, 2004 and 2003.


LIQUIDITY AND CAPITAL RESOURCES

At August 31, 2004, Twistee Treat has negative working capital of $253,033
compared to negative working capital of $247,452 at November 30, 2003.

Cash shortfall provided from operating activities decreased to ($1,954) from
($113,968).

The Company has no credit line or other bank debt, and has in the past generated
cash from the sale of its common stock.  At August 31, 2004, the Company had a
stockholders' deficit of $253,033, a decrease of approximately 11% from $182,954
of stockholders' deficit existing at November 30, 2003.

As reflected in the accompanying financial statements and at August 31, 2004,
the Company has a working capital deficit of $253,033 and a net loss from
operations of $130,076 for the nine months ended August 31, 2004. The Company's
operations are not sufficient to finance its growth. The ability of the Company
to continue as a going concern is dependent upon its ability to raise additional
capital and implement its business plan. The Company anticipates issuing
additional debt and equity securities and reducing operating overhead.
Management believes that actions presently taken to improve its future
operations and obtain additional funding provide the opportunity for the Company
to continue as a going concern.

                                      -7-
<PAGE>

Factors That May Affect Future Results

Dependence Upon External Financing:  The Company has been building its business
through revenues generated from operations, supplemented by the sale of its
capital common stock.  The ability of the Company to continue to grow and expand
its business is highly dependent upon the ability of the Company to continue to
raise external financing, from the sale of equity and/or the incurrence of debt.
If the Company were unable to obtain debt and/or equity financing upon terms
that were sufficiently favorable to the Company, or at all, it would have a
materially adverse impact upon the ability of the Company to continue to expand
its business and operations, or to implement its business plan as now
contemplated by the Company.

Reliance on Key Management:  The success of the Company is highly dependent upon
the continued services of James A. Tilton, its President and Chief Financial
Officer, who is the primary person responsible for building the Company's
renewed franchises, regional development and licensing business.  If he were to
leave the Company, it could have a materially adverse effect upon the business
and operations of the Company.

CRITICAL ACCOUNTING POLICIES

Our discussion and analysis of our financial condition and results of operations
is based upon our audited financial statements, which have been prepared in
accordance with accounting principals generally accepted in the United States.
The preparation of these financial statements requires us to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues and
expenses, and related disclosure of any contingent assets and liabilities.  On
an on-going basis, we evaluate our estimates, including those related to
uncollectible receivable, investment values, income taxes, the recapitalization
and contingencies.  We base our estimates on various assumptions that we believe
to be reasonable under the circumstances, the results of which form the basis
for making judgments about carrying values of assets and liabilities that are
not readily apparent from other sources.  Actual results may differ from these
estimates under different assumptions or conditions.

We believe the following critical accounting policies affect our more
significant judgments and estimates used in the preparation of our financial
statements:

Impairment of Long-Lived Assets

Property and equipment are stated at cost less accumulated depreciation.  Major
renewals and improvements are capitalized; minor replacements, maintenance and
repairs are charged to current operations. Depreciation is computed by applying
the straight-line method over the estimated useful lives of machinery and
equipment (10 years).  Twistee performs reviews for the impairment of long-lived
assets whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable.

                                      -8-
<PAGE>

OTHER INFORMATION

ITEM 1: Legal Proceedings

Twistee Treat has a dispute with a law firm regarding past due fees. The law
firm Feldhake, August & Roquemore LLP received a default judgment for $16,349.94
composed of principal and interest on May 28, 2002 in the Superior Court of
California, County of Orange styled as case number 01HL04797.

ITEM 3.   CONTROLS AND PROCEDURES

Our principal executive officer and principal financial officer evaluated the
effectiveness of our disclosure controls and procedures as (as such term is
defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of
1934, as amended) as of the end of the period covered by this report. Based on
this evaluation, our principal executive officer and principal financial officer
have concluded that our controls and procedures are effective in providing
reasonable assurance that the information required to be disclosed in this
report is accurate and complete and has been recorded, processed, summarized and
reported as of the end of the period covered by this report. During the fiscal
quarter covered by this report, there have not been any significant changes in
our internal controls or, to our knowledge, in other factors that could
significantly affect our internal controls.


PART II - OTHER INFORMATION

Item 2.  Changes In Securities

None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

a)     Exhibits

Exhibit No.     Description

31.1          Certificate of the Chief Executive
              Officer pursuant Section 302 of the
              Sarbanes-Oxley Act of 2002               *

32.1          Certificate of the Chief Executive
              Officer pursuant to Section 906 of the
              Sarbanes-Oxley Act of 2002               *

* Filed Herein.

b)     REPORTS ON FORM 8-K

The Company filed the following report on Form 8-K during the quarter for
which this report is filed:

On November 12, 2004, we filed a Current Report on Form 8-K reporting that on
November 5, 2004, we dismissed Malone & Bailey, PLLC, as our independent
auditors and hired Lopez, Blevins, Bork & Associates, LLP, as our independent
auditors. (Items 4.01 and 9.01)

                                      -9-
<PAGE>

SIGNATURES

In accordance with the requirements of the Exchange Act, the Registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

TWISTEE TREAT CORPORATION

Dated: November 2, 2004

By:  /s/ JAMES A. TILTON
----------------------------------
James A. Tilton
President and Chief Financial Officer


                                      -10-
<PAGE>

EXHIBIT 31.1


                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
            PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, James A. Tilton, certify  that:

1.   I have reviewed this Annual Report on Form 10-QSB of Twistee Treat
     Corporation;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the small business issuer as of, and for, the periods presented in this
     report;

4.   The small business issuer's other certifying officer and I are responsible
     for establishing and maintaining disclosure controls and procedures (as
     defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small
     business issuer and have:

     (a)  Designed such disclosure controls and procedures, or caused such
          disclosure controls and procedures to be designed under our
          supervision, to ensure that material information relating to the small
          business issuer, including its consolidated subsidiaries, is made
          known to us by others within those entities, particularly during the
          period in which this report is being prepared;

     (b)  Paragraph omitted in accordance with SEC transition instructions
          contained in SEC Release No. 33-8238;

     (c)  Evaluated the effectiveness of the small business issuer's disclosure
          controls and procedures and presented in this report our conclusions
          about the effectiveness of the disclosure controls and procedures, as
          of the end of the period covered by this report based on such
          evaluation; and

     (d)  Disclosed in this report any change in the small business issuer's
          internal control over financial reporting that occurred during the
          small business issuer's most recent fiscal quarter (the small business
          issuer's fourth fiscal quarter in the case of an annual report) that
          has materially affected, or is reasonably likely to materially affect,
          the small business issuer's internal control over financial reporting;
          and

5.   The small business issuer's other certifying officer and I have disclosed,
     based on our most recent evaluation of internal control over financial
     reporting, to the small business issuer's auditors and the audit committee
     of the small business issuer's board of directors (or persons performing
     the equivalent functions):

     (a)  All significant deficiencies and material weaknesses in the design or
          operation of internal control over financial reporting which are
          reasonably likely to adversely affect the small business issuer's
          ability to record, process, summarize and report financial
          information; and

     (b)  Any fraud, whether or not material, that involves management or other
          employees who have a significant role in the small business issuer's
          internal control over financial reporting.

Date:  November 2,  2004

By:  /s/  James A. Tilton
-------------------------------
James A. Tilton
President and Chief Financial Officer

<PAGE>


EXHIBIT 32.1


                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
           PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, James A. Tilton, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report of Twistee Treat Corporation on Form 10-QSB for the quarter ended August
31, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that information contained in such Form
10-QSB fairly presents in all material respects the financial condition and
results of operations of Twistee Treat Corporation

Date:  November 2, 2004

By:/s/ James A. Tilton
--------------------------
James A. Tilton
President and Chief Financial Officer

<PAGE>